Search research articles
Contact Us
Filters
Showing results (1-10 of 318) with videos related to
Page
of 32
Sort By:
The Journal of Clinical Investigation
|
September 15, 2022
A world without tuberculosis: moving from imagination to reality
William R Jacobs
Microbiology Spectrum
|
June 25, 2015
Gene Transfer in Mycobacterium tuberculosis: Shuttle Phasmids to Enlightenment
William R Jacobs
Microbiology Spectrum
|
June 25, 2015
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities
Catherine Vilchèze, William R Jacobs
Methods in Molecular Biology (Clifton, N.J.)
|
June 19, 2010
Gene essentiality testing in mycobacterium smegmatis using specialized transduction
Apoorva Bhatt, William R Jacobs
Journal of Molecular Biology
|
February 25, 2019
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis
Catherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy
|
July 25, 2012
The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis
Catherine Vilchèze, William R Jacobs
Drug News & Perspectives
|
December 25, 2010
The significance of GlgE as a new target for tuberculosis
Rainer Kalscheuer, William R Jacobs
Antimicrobial Agents and Chemotherapy
|
February 23, 2021
The promises and limitations of <i>N-</i>acetylcysteine as a potentiator of first-line and second-line tuberculosis drugs
Catherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy
|
October 26, 2018
Reply to Yew et al., "Vitamin C and Mycobacterium tuberculosis Persisters"
Catherine Vilchèze, William R Jacobs
Current Protocols in Microbiology
|
September 5, 2008
Isolation and analysis of Mycobacterium tuberculosis mycolic acids
Catherine Vilchèze, William R Jacobs
Page
of 32
Search research articles
Search
Showing results (1-10 of 318) with videos related to
Sort By:
Page
of 32
The Journal of Clinical Investigation
|
September 15, 2022
A world without tuberculosis: moving from imagination to reality
William R Jacobs
Microbiology Spectrum
|
June 25, 2015
Gene Transfer in Mycobacterium tuberculosis: Shuttle Phasmids to Enlightenment
William R Jacobs
Microbiology Spectrum
|
June 25, 2015
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities
Catherine Vilchèze, William R Jacobs
Methods in Molecular Biology (Clifton, N.J.)
|
June 19, 2010
Gene essentiality testing in mycobacterium smegmatis using specialized transduction
Apoorva Bhatt, William R Jacobs
Journal of Molecular Biology
|
February 25, 2019
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis
Catherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy
|
July 25, 2012
The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis
Catherine Vilchèze, William R Jacobs
Drug News & Perspectives
|
December 25, 2010
The significance of GlgE as a new target for tuberculosis
Rainer Kalscheuer, William R Jacobs
Antimicrobial Agents and Chemotherapy
|
February 23, 2021
The promises and limitations of <i>N-</i>acetylcysteine as a potentiator of first-line and second-line tuberculosis drugs
Catherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy
|
October 26, 2018
Reply to Yew et al., "Vitamin C and Mycobacterium tuberculosis Persisters"
Catherine Vilchèze, William R Jacobs
Current Protocols in Microbiology
|
September 5, 2008
Isolation and analysis of Mycobacterium tuberculosis mycolic acids
Catherine Vilchèze, William R Jacobs
Page
of 32